☰

Hua Pan, Ph.D. - Publications

Institution:
Washington University, Saint Louis, St. Louis, MO
Area:
K channels
Tree Info Grants Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Zhou Q, Doherty J, Akk A, Springer LE, Fan P, Spasojevic I, Halade GV, Yang H, Pham CTN, Wickline SA, Pan H. Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury. Nanomaterials (Basel, Switzerland). 12. PMID 35159680 DOI: 10.3390/nano12030336  0.534
2020 Zhang Y, Le T, Grabau R, Mohseni Z, Kim H, Natale DR, Feng L, Pan H, Yang H. TMEM16F phospholipid scramblase mediates trophoblast fusion and placental development. Science Advances. 6: eaba0310. PMID 32494719 DOI: 10.1126/Sciadv.Aba0310  0.542
2020 Yan H, Hu Y, Akk A, Rai MF, Pan H, Wickline SA, Pham CTN. Induction of WNT16 via Peptide-mRNA Nanoparticle-Based Delivery Maintains Cartilage Homeostasis. Pharmaceutics. 12. PMID 31963412 DOI: 10.3390/Pharmaceutics12010073  0.31
2019 Strand MS, Krasnick BA, Pan H, Zhang X, Bi Y, Brooks C, Wetzel C, Sankpal N, Fleming T, Goedegebuure SP, DeNardo DG, Gillanders WE, Hawkins WG, Wickline SA, Fields RC. Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles. Oncotarget. 10: 4761-4775. PMID 31413817 DOI: 10.18632/Oncotarget.27109  0.373
2019 Rai MF, Pan H, Yan H, Sandell LJ, Pham CTN, Wickline SA. Applications of RNA interference in the treatment of arthritis. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 31351032 DOI: 10.1016/J.Trsl.2019.07.002  0.303
2019 Mills KA, Quinn JM, Roach ST, Palisoul M, Nguyen M, Noia H, Guo L, Fazal J, Mutch DG, Wickline SA, Pan H, Fuh KC. p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts. Scientific Reports. 9: 4762. PMID 30886159 DOI: 10.1038/S41598-019-41122-3  0.344
2019 Yan H, Duan X, Pan H, Akk A, Sandell LJ, Wickline SA, Rai MF, Pham CTN. Development of a peptide-siRNA nanocomplex targeting NF- κB for efficient cartilage delivery. Scientific Reports. 9: 442. PMID 30679644 DOI: 10.1038/S41598-018-37018-3  0.333
2019 Pan H, Grabau R, Vargas I, Baldwin M, Cara B, Stephenson D, Lindon A, Chalfant C, Wickline S. P702Anti-thrombin nanoparticles for reduce vascular damage and promote functional recovery in acute ischemic kidney injury well after reperfusion European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz747.0307  0.33
2018 Mills K, Quinn J, Roach S, Palisoul M, Hagemann A, Thaker P, Powell M, Mutch D, Wickline S, Pan H, Fuh K. A novel nanoparticle platform, p5RHH-siAXL, inhibits metastasis in gynecologic serous cancers Gynecologic Oncology. 149: 69-70. DOI: 10.1016/J.Ygyno.2018.04.158  0.3
2017 Krasnick B, Strand MS, Bi Y, Goedegebuure PS, Fleming T, Wickline SA, Pan H, Fields RC. Anti-KRAS siRNA nanoparticles for targeted colorectal cancer therapy. Journal of Clinical Oncology. 35: 636-636. DOI: 10.1200/Jco.2017.35.4_Suppl.636  0.323
2017 Strand MS, Pan H, Krasnick B, Zhang X, Goedegebuure PS, Fleming T, DeNardo DG, Gillanders WE, Hawkins WG, Wickline SA, Fields RC. Precision delivery of RAS-inhibiting siRNA to pancreatic cancer via peptide-based nanoparticles. Journal of Clinical Oncology. 35: 287-287. DOI: 10.1200/Jco.2017.35.4_Suppl.287  0.358
2017 Mills K, Palisoul M, Quinn J, Hagemann A, Thaker P, Powell M, Mutch D, Wickline S, Pan H, Fuh K. P5RHH-siAXL nanoparticle is a novel targeted therapy in metastatic gynecologic serous cancers Gynecologic Oncology. 145: 118. DOI: 10.1016/J.Ygyno.2017.03.277  0.305
2016 Lozhkin A, Vendrov AE, Pan H, Wickline SA, Madamanchi NR, Runge MS. NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis. Journal of Molecular and Cellular Cardiology. PMID 27986445 DOI: 10.1016/J.Yjmcc.2016.12.004  0.301
2016 Yan H, Duan X, Pan H, Holguin N, Rai MF, Akk A, Springer LE, Wickline SA, Sandell LJ, Pham CT. Suppression of NF-κB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury. Proceedings of the National Academy of Sciences of the United States of America. PMID 27681622 DOI: 10.1073/Pnas.1608245113  0.33
2016 Palekar RU, Jallouk AP, Myerson JW, Pan H, Wickline SA. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26769047 DOI: 10.1161/Atvbaha.115.306697  0.324
2016 Strand MS, Pan H, Grossman JG, Goedegebuure PS, Fleming T, Wickline SA, Fields RC. Precision cancer therapy through nanoparticle delivery of siRNA against KRAS. Journal of Clinical Oncology. 34: 260-260. DOI: 10.1200/Jco.2016.34.4_Suppl.260  0.352
2016 Palisoul M, Nguyen M, Pan H, Lohrey A, Wickline S, Powell M, Mutch D, Fuh K. Abstract LB-060: A novel target for genetic silencing of AXL mediates taxane resistance, invasion, and migration in uterine cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-060  0.308
2016 Strand M, Pan H, Zhang X, Grossman J, Goedegebuure P, Fleming T, Gillanders WE, Wickline SA, Fields RC. Abstract 1080: Kras downregulation by nanoparticle delivery of siRNA reduces tumor growth in mice Cancer Research. 76: 1080-1080. DOI: 10.1158/1538-7445.Am2016-1080  0.349
2015 Pham CT, Pan H, Wickline SA. Peptide-siRNA nanotherapeutics in arthritis. Oncotarget. 6: 14731-2. PMID 26142704 DOI: 10.18632/Oncotarget.4439  0.38
2015 Jallouk AP, Palekar RU, Marsh JN, Pan H, Pham CT, Schlesinger PH, Wickline SA. Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles. Bioconjugate Chemistry. 26: 1640-50. PMID 26083278 DOI: 10.1021/Acs.Bioconjchem.5B00246  0.356
2015 Hou KK, Pan H, Schlesinger PH, Wickline SA. A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin. Biotechnology Advances. 33: 931-40. PMID 26025036 DOI: 10.1016/J.Biotechadv.2015.05.005  0.335
2015 Jallouk AP, Palekar RU, Pan H, Schlesinger PH, Wickline SA. Modifications of natural peptides for nanoparticle and drug design. Advances in Protein Chemistry and Structural Biology. 98: 57-91. PMID 25819276 DOI: 10.1016/Bs.Apcsb.2014.12.001  0.329
2015 Jallouk A, Palekar R, Pan H, Schlesinger P, Wickline S. Nanoparticle-Bound Cytolytic Peptide Prodrugs for Cancer Therapy The Faseb Journal. 29. DOI: 10.1096/Fasebj.29.1_Supplement.620.6  0.341
2014 Zhou HF, Yan H, Pan H, Hou KK, Akk A, Springer LE, Hu Y, Allen JS, Wickline SA, Pham CT. Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis. The Journal of Clinical Investigation. 124: 4363-74. PMID 25157820 DOI: 10.1172/Jci75673  0.306
2014 Pan H, Myerson J, Yang X, Lanza G, Wickline SA. Atherosclerosis endothelial activation quantification in vivo with fluorine magnetic resonance imaging and spectroscopy Journal of Cardiovascular Magnetic Resonance. 16. DOI: 10.1186/1532-429X-16-S1-O91  0.306
2013 Chen J, Pan H, Lanza GM, Wickline SA. Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy. Advances in Chronic Kidney Disease. 20: 466-78. PMID 24206599 DOI: 10.1053/J.Ackd.2013.08.004  0.317
2013 Palekar RU, Myerson JW, Schlesinger PH, Sadler JE, Pan H, Wickline SA. Thrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis. Molecular Pharmaceutics. 10: 4168-75. PMID 24063304 DOI: 10.1021/Mp400210Q  0.318
2013 Hou KK, Pan H, Ratner L, Schlesinger PH, Wickline SA. Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides. Acs Nano. 7: 8605-15. PMID 24053333 DOI: 10.1021/Nn403311C  0.321
2013 Hou KK, Pan H, Lanza GM, Wickline SA. Melittin derived peptides for nanoparticle based siRNA transfection. Biomaterials. 34: 3110-9. PMID 23380356 DOI: 10.1016/J.Biomaterials.2013.01.037  0.373
2013 Pan H, Myerson JW, Hu L, Marsh JN, Hou K, Scott MJ, Allen JS, Hu G, San Roman S, Lanza GM, Schreiber RD, Schlesinger PH, Wickline SA. Programmable nanoparticle functionalization for in vivo targeting. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 255-64. PMID 23047896 DOI: 10.1096/Fj.12-218081  0.349
2012 Pan H, Marsh JN, Christenson ET, Soman NR, Ivashyna O, Lanza GM, Schlesinger PH, Wickline SA. Postformulation peptide drug loading of nanostructures. Methods in Enzymology. 508: 17-39. PMID 22449919 DOI: 10.1016/B978-0-12-391860-4.00002-1  0.325
2011 Pan H, Soman NR, Schlesinger PH, Lanza GM, Wickline SA. Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 3: 318-27. PMID 21225660 DOI: 10.1002/Wnan.126  0.351
2011 Pan H, Ivashyna O, Sinha B, Lanza GM, Ratner L, Schlesinger PH, Wickline SA. Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling. Biomaterials. 32: 231-8. PMID 20864161 DOI: 10.1016/J.Biomaterials.2010.08.080  0.34
2010 Wu D, Pan H, Delaloye K, Cui J. KCNE1 remodels the voltage sensor of Kv7.1 to modulate channel function. Biophysical Journal. 99: 3599-608. PMID 21112284 DOI: 10.1016/J.Bpj.2010.10.018  0.609
2010 Pan H, Myerson JW, Ivashyna O, Soman NR, Marsh JN, Hood JL, Lanza GM, Schlesinger PH, Wickline SA. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 2928-37. PMID 20335225 DOI: 10.1096/Fj.09-153130  0.356
2010 Pan H, Ivashyna O, Hood JL, Christenson E, Lanza GM, Schlesinger PH, Wickline SA. Structural Modifications to Convert Melittin from a Cytolytic Peptide to a Stable Cargo Linker Biophysical Journal. 98: 276a-277a. DOI: 10.1016/J.Bpj.2009.12.1511  0.335
2009 Silva JR, Pan H, Wu D, Nekouzadeh A, Decker KF, Cui J, Baker NA, Sept D, Rudy Y. A multiscale model linking ion-channel molecular dynamics and electrostatics to the cardiac action potential. Proceedings of the National Academy of Sciences of the United States of America. 106: 11102-6. PMID 19549851 DOI: 10.1073/Pnas.0904505106  0.614
2005 Pan H, Zhou Y, Izadnegahdar O, Cui J, Deng CX. Study of sonoporation dynamics affected by ultrasound duty cycle. Ultrasound in Medicine & Biology. 31: 849-56. PMID 15936500 DOI: 10.1016/J.Ultrasmedbio.2005.03.014  0.542
2004 Deng CX, Sieling F, Pan H, Cui J. Ultrasound-induced cell membrane porosity. Ultrasound in Medicine & Biology. 30: 519-26. PMID 15121254 DOI: 10.1016/J.Ultrasmedbio.2004.01.005  0.522
Show low-probability matches.